Related references
Note: Only part of the references are listed.Skeletal muscle loss: cachexia, sarcopenia, and inactivity
William J. Evans
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Polymyositis, dermatomyositis and malignancy: A further intriguing link
S. Zampieri et al.
AUTOIMMUNITY REVIEWS (2010)
Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies
S. Zampieri et al.
NEUROLOGICAL RESEARCH (2010)
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice
K. van Norren et al.
BRITISH JOURNAL OF CANCER (2009)
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B. Cambien et al.
BRITISH JOURNAL OF CANCER (2009)
Mouse models for the study of colon carcinogenesis
Daniel W. Rosenberg et al.
CARCINOGENESIS (2009)
Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
A. Bonetto et al.
CURRENT CANCER DRUG TARGETS (2009)
From cancer genomes to cancer models: bridging the gaps
Anaies Baudot et al.
EMBO REPORTS (2009)
Mouse Models of Colon Cancer
Makoto Mark Taketo et al.
GASTROENTEROLOGY (2009)
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
Shenhav Cohen et al.
JOURNAL OF CELL BIOLOGY (2009)
Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
Philipp Weyermann et al.
PLOS ONE (2009)
Modulation of Caspase Activity Regulates Skeletal Muscle Regeneration and Function in Response to Vasopressin and Tumor Necrosis Factor
Viviana Moresi et al.
PLOS ONE (2009)
Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf-1 transgenic skeletal muscle
Zaccaria Del Prete et al.
ANNALS OF BIOMEDICAL ENGINEERING (2008)
Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia
J. Faber et al.
BRITISH JOURNAL OF CANCER (2008)
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation
Weiwei Feng et al.
CANCER (2008)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice
Michela Alessandra Denti et al.
HUMAN GENE THERAPY (2008)
A novel role for CD4+ T cells in the control of cachexial
Zhuangzhi Wang et al.
JOURNAL OF IMMUNOLOGY (2008)
Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice
Emanuele Berardi et al.
NEUROLOGICAL RESEARCH (2008)
Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation
S. Schastak et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2008)
Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response
Viviana Moresi et al.
STEM CELLS (2008)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
The lethal phenotype of cancer: The molecular basis of death due to malignancy
Robert D. Loberg et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny
Michael J. Conboy et al.
PLOS BIOLOGY (2007)
Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway
Martina Schwarzkopf et al.
GENES & DEVELOPMENT (2006)
Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice
Stuart Hodgetts et al.
NEUROMUSCULAR DISORDERS (2006)
Text similarity: an alternative way to search MEDLINE
James Lewis et al.
BIOINFORMATICS (2006)
Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice
Sue E. Samuels et al.
CANCER LETTERS (2006)
Multiple imprinted and sternness genes provide a link between normal and tumor progenitor cells of the developing human kidney
B Dekel et al.
CANCER RESEARCH (2006)
Mass-dependent decline of skeletal muscle function in cancer cachexia
M Gorselink et al.
MUSCLE & NERVE (2006)
Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis
LM Veenendaal et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer
Raymond M. Schiffelers et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration
D Coletti et al.
GENESIS (2005)
Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia
S Acharyya et al.
CANCER CELL (2005)
A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040
YL Wang et al.
NEOPLASIA (2005)
Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model
HK van Halteren et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT
M Hisada et al.
CANCER GENE THERAPY (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis
C Melani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma
DO McCarthy et al.
RESEARCH IN NURSING & HEALTH (2004)
Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma
YJL Kamm et al.
BRITISH JOURNAL OF CANCER (2003)
Enhancement of colon carcinogenesis by prostaglandin E2 administration
T Kawamori et al.
CARCINOGENESIS (2003)
Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines
J Wiegant et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Altered expression of skeletal muscle myosin isoforms in cancer cachexia
GM Diffee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Share Paper
